INAB
INAB
NASDAQ · Biotechnology

In8Bio Inc

$1.99
+0.09 (+4.74%)
As of Feb 8, 2:24 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 7.34M 7.69M 6.20M
Net Income 836.8K 704.4K 655.3K
EPS
Profit Margin 11.4% 9.2% 10.6%
Rev Growth +8.2% -3.9% -5.2%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 2.59M 2.45M 2.40M
Total Equity 13.81M 12.60M 13.17M
D/E Ratio 0.19 0.19 0.18
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 1.33M 1.40M 1.15M
Free Cash Flow 524.0K 541.1K 340.9K